(4-Methyl-2-(pyridin-3-yl)thiazol-5-yl)methanol
95%
- Product Code: 85484
CAS:
886851-57-6
| Molecular Weight: | 206.26 g./mol | Molecular Formula: | C₁₀H₁₀N₂OS |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD09817497 | |
| Melting Point: | 156-157.5 °C | Boiling Point: | |
| Density: | Storage Condition: | 2-8°C, dry, sealed |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting specific enzymes or receptors. Its structure, which includes both thiazole and pyridine moieties, makes it valuable for designing compounds with potential therapeutic applications, such as anti-inflammatory, antimicrobial, or anticancer agents. Researchers often modify its functional groups to enhance drug-like properties, including solubility, stability, and binding affinity. Additionally, it may be employed in the development of small-molecule inhibitors for studying biochemical pathways or as a scaffold for creating novel drug candidates.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | £140.45 |
+
-
|
| 0.250 | 10-20 days | £293.12 |
+
-
|
(4-Methyl-2-(pyridin-3-yl)thiazol-5-yl)methanol
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting specific enzymes or receptors. Its structure, which includes both thiazole and pyridine moieties, makes it valuable for designing compounds with potential therapeutic applications, such as anti-inflammatory, antimicrobial, or anticancer agents. Researchers often modify its functional groups to enhance drug-like properties, including solubility, stability, and binding affinity. Additionally, it may be employed in the development of small-molecule inhibitors for studying biochemical pathways or as a scaffold for creating novel drug candidates.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :